Sensitivity analysis of FDA´s benchmark nozzle regarding in vitro imperfections - Do we need asymmetric CFD benchmarks?

Modern technologies and methods such as computer simulation, so-called in silico methods, foster the development of medical devices. For accelerating the uptake of computer simulations and to increase credibility and reliability the U.S. Food and Drug Administration organized an inter-laboratory rou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stiehm Michael, Brandt-Wunderlich Christoph, Siewert Stefan, Schmitz Klaus-Peter, Grabow Niels, Goubergrits Leonid, Kühne Titus, Poon Eric K. W., Ooi Andrew, Barlis Peter
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2020
Materias:
R
Acceso en línea:https://doaj.org/article/c22ccd023c4a4a319f78c935001a79e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!